Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Haruaki Nobori"'
Autor:
Michihito Sasaki, Tatsuki Sugi, Shun Iida, Yuichiro Hirata, Shinji Kusakabe, Kei Konishi, Yukari Itakura, Koshiro Tabata, Mai Kishimoto, Hiroko Kobayashi, Takuma Ariizumi, Kittiya Intaruck, Haruaki Nobori, Shinsuke Toba, Akihiko Sato, Keita Matsuno, Junya Yamagishi, Tadaki Suzuki, William W. Hall, Yasuko Orba, Hirofumi Sawa
Publikováno v:
EBioMedicine, Vol 99, Iss , Pp 104950- (2024)
Summary: Background: Pulmonary infection with SARS-CoV-2 stimulates host immune responses and can also result in the progression of dysregulated and critical inflammation. Throughout the pandemic, the management and treatment of COVID-19 has been con
Externí odkaz:
https://doaj.org/article/dacbe28b2d6c43a19dbad2a02ee57c67
Autor:
Keita Fukao, Haruaki Nobori, Takayuki Kuroda, Kaoru Baba, Kazumi Matsumoto, Yukari Tanaka, Yuki Tachibana, Teruhisa Kato, Takao Shishido
Publikováno v:
Viruses, Vol 15, Iss 10, p 2052 (2023)
The small-molecule antiviral drug ensitrelvir targets the 3C-like protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study evaluated its inhibitory effect on viral replication in a delayed-treatment mouse model and investi
Externí odkaz:
https://doaj.org/article/d5518e9b9d154508a307272554b1b36c
Autor:
Kentaro Uemura, Haruaki Nobori, Akihiko Sato, Takao Sanaki, Shinsuke Toba, Michihito Sasaki, Akiho Murai, Noriko Saito-Tarashima, Noriaki Minakawa, Yasuko Orba, Hiroaki Kariwa, William W. Hall, Hirofumi Sawa, Akira Matsuda, Katsumi Maenaka
Publikováno v:
iScience, Vol 24, Iss 10, Pp 103120- (2021)
Summary: Newly emerging or re-emerging viral infections continue to cause significant morbidity and mortality every year worldwide, resulting in serious effects on both health and the global economy. Despite significant drug discovery research agains
Externí odkaz:
https://doaj.org/article/88a87cb6ba924ad085f68b46be907e5f
Autor:
Keiichi Taniguchi, Yoshinori Ando, Masanori Kobayashi, Shinsuke Toba, Haruaki Nobori, Takao Sanaki, Takeshi Noshi, Makoto Kawai, Ryu Yoshida, Akihiko Sato, Takao Shishido, Akira Naito, Keita Matsuno, Masatoshi Okamatsu, Yoshihiro Sakoda, Hiroshi Kida
Publikováno v:
Viruses, Vol 14, Iss 1, p 111 (2022)
Human infections caused by the H5 highly pathogenic avian influenza virus (HPAIV) sporadically threaten public health. The susceptibility of HPAIVs to baloxavir acid (BXA), a new class of inhibitors for the influenza virus cap-dependent endonuclease,
Externí odkaz:
https://doaj.org/article/2992f7db62694e5e81d10f333c956cd5
Autor:
Yoshiaki Okada, Haruaki Nobori, Mikiko Shimizu, Miho Watanabe, Masaaki Yonekura, Tomoko Nakai, Yuko Kamikawa, Atsuko Wakimura, Nobuaki Funahashi, Hiroki Naruse, Ayako Watanabe, Daisuke Yamasaki, So-ichiro Fukada, Kazuta Yasui, Kayoko Matsumoto, Takahiro Sato, Kenji Kitajima, Toru Nakano, William C Aird, Takefumi Doi
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24837 (2011)
In previous studies on the mechanism underlying megakaryocyte-specific gene expression, several ETS motifs were found in each megakaryocyte-specific gene promoter. Although these studies suggested that several ETS family proteins regulate megakaryocy
Externí odkaz:
https://doaj.org/article/06786d4d88f549fc9972867b315f5a43
Autor:
Takayuki Kuroda, Haruaki Nobori, Keita Fukao, Kaoru Baba, Kazumi Matsumoto, Shinpei Yoshida, Yukari Tanaka, Ryosuke Watari, Ryoko Oka, Yasuyuki Kasai, Kae Inoue, Sho Kawashima, Alice Shimba, Yoko Hayasaki-Kajiwara, Miki Tanimura, Qianhui Zhang, Yuki Tachibana, Teruhisa Kato, Takao Shishido
Publikováno v:
Journal of Antimicrobial Chemotherapy. 78:946-952
Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become established in the human population, making the need to develop safe and effective treatments critical. We have developed the small-molecule antiviral ensitrelvir, whi
Autor:
Sho Kawashima, Yuki Matsui, Takumi Adachi, Yuji Morikawa, Kae Inoue, Shiori Takebayashi, Haruaki Nobori, Masatomo Rokushima, Yuki Tachibana, Teruhisa Kato
Publikováno v:
Biochemical and Biophysical Research Communications. 645:132-136
Autor:
Yuto Unoh, Shota Uehara, Kenji Nakahara, Haruaki Nobori, Yukiko Yamatsu, Shiho Yamamoto, Yuki Maruyama, Yoshiyuki Taoda, Koji Kasamatsu, Takahiro Suto, Kensuke Kouki, Atsufumi Nakahashi, Sho Kawashima, Takao Sanaki, Shinsuke Toba, Kentaro Uemura, Tohru Mizutare, Shigeru Ando, Michihito Sasaki, Yasuko Orba, Hirofumi Sawa, Akihiko Sato, Takafumi Sato, Teruhisa Kato, Yuki Tachibana
Publikováno v:
Journal of Medicinal Chemistry. 65:6499-6512
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths and threatens public health and safety. Despite the rapid global spread of COVID-19 vaccines,
Autor:
Michihito Sasaki, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hiroko Kobayashi, Takuma Ariizumi, Kentaro Uemura, Shinsuke Toba, Shinji Kusakabe, Yuki Maruyama, Shun Iida, Noriko Nakajima, Tadaki Suzuki, Shinpei Yoshida, Haruaki Nobori, Takao Sanaki, Teruhisa Kato, Takao Shishido, William W. Hall, Yasuko Orba, Akihiko Sato, Hirofumi Sawa
Publikováno v:
Science Translational Medicine. 15
In parallel with vaccination, oral antiviral agents are highly anticipated to act as countermeasures for the treatment of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Oral an
Autor:
Kentaro Uemura, Haruaki Nobori, Akihiko Sato, Shinsuke Toba, Shinji Kusakabe, Michihito Sasaki, Koshiro Tabata, Keita Matsuno, Naoyoshi Maeda, Shiori Ito, Mayu Tanaka, Yuki Anraku, Shunsuke Kita, Mayumi Ishii, Kayoko Kanamitsu, Yasuko Orba, Yoshiharu Matsuura, William W. Hall, Hirofumi Sawa, Hiroshi Kida, Akira Matsuda, Katsumi Maenaka
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes significant morbidity and mortality worldwide, seriously impacting not only human health but also the global economy. Furthermore, over 1 million cases of newly emerging or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51e945be18e4a2e3258c4022e358ed51
https://doi.org/10.1101/2022.12.14.520006
https://doi.org/10.1101/2022.12.14.520006